Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $27.1B
1-Year Return 23.24%
This Quarter Return
+7.66%
1 Year Return
+23.24%
3 Year Return
+64.59%
5 Year Return
+118.48%
10 Year Return
+210.79%
AUM
$14.4B
AUM Growth
+$1.36B
Cap. Flow
+$220M
Cap. Flow %
1.53%
Top 10 Hldgs %
37.22%
Holding
1,339
New
25
Increased
736
Reduced
239
Closed
23

Sector Composition

1 Real Estate 55.07%
2 Technology 11.49%
3 Consumer Discretionary 4.63%
4 Healthcare 4.39%
5 Communication Services 3.94%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
EDIT icon
1176
Editas Medicine
EDIT
$247M
$2K ﹤0.01%
277
FATE icon
1177
Fate Therapeutics
FATE
$115M
$2K ﹤0.01%
360
FDMT icon
1178
4D Molecular Therapeutics
FDMT
$339M
$2K ﹤0.01%
130
GLPG icon
1179
Galapagos
GLPG
$2.2B
$2K ﹤0.01%
51
HCM icon
1180
HUTCHMED
HCM
$2.75B
$2K ﹤0.01%
185
HLVX icon
1181
HilleVax
HLVX
$105M
$2K ﹤0.01%
134
HROW icon
1182
Harrow
HROW
$1.37B
$2K ﹤0.01%
110
ITOS
1183
DELISTED
iTeos Therapeutics
ITOS
$2K ﹤0.01%
121
SPRY icon
1184
ARS Pharmaceuticals
SPRY
$995M
$2K ﹤0.01%
+367
New +$2K
SRRK icon
1185
Scholar Rock
SRRK
$3.02B
$2K ﹤0.01%
208
TBPH icon
1186
Theravance Biopharma
TBPH
$702M
$2K ﹤0.01%
215
TERN icon
1187
Terns Pharmaceuticals
TERN
$631M
$2K ﹤0.01%
151
TSVT
1188
DELISTED
2seventy bio
TSVT
$2K ﹤0.01%
152
WVE icon
1189
Wave Life Sciences
WVE
$1.32B
$2K ﹤0.01%
349
ME
1190
DELISTED
23andMe Holding Co. Class A Common Stock
ME
$2K ﹤0.01%
+48
New +$2K
NSTG
1191
DELISTED
NanoString Technologies, Inc.
NSTG
$2K ﹤0.01%
156
ICPT
1192
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$2K ﹤0.01%
167
LYEL icon
1193
Lyell Immunopharma
LYEL
$235M
$2K ﹤0.01%
46
MRSN icon
1194
Mersana Therapeutics
MRSN
$34.1M
$2K ﹤0.01%
16
NVAX icon
1195
Novavax
NVAX
$1.28B
$2K ﹤0.01%
291
RAPT icon
1196
RAPT Therapeutics
RAPT
$218M
$2K ﹤0.01%
13
SIGA icon
1197
SIGA Technologies
SIGA
$603M
$2K ﹤0.01%
270
ANAB icon
1198
AnaptysBio
ANAB
$612M
$2K ﹤0.01%
105
AVDL
1199
Avadel Pharmaceuticals
AVDL
$1.53B
$2K ﹤0.01%
245
BCYC
1200
Bicycle Therapeutics
BCYC
$496M
$2K ﹤0.01%
103